Greg Stroup

Protection against Congenital Cytomegalovirus Infection and Disease in Guinea Pigs, Conferred by a Purified Recombinant Glycoprotein B Vaccine

Mark R. Schleiss, Nigel Bourne, Greg Stroup et al. · The Journal of Infectious Diseases · 2004 · 99 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Preconceptual Administration of an Alphavirus Replicon UL83 (pp65 Homolog) Vaccine Induces Humoral and Cellular Immunity and Improves Pregnancy Outcome in the Guinea Pig Model of Congenital Cytomegalovirus Infection

Mark R. Schleiss, Juan C. Lacayo, Yasmine Belkaid et al. · The Journal of Infectious Diseases · 2007 · 71 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Efficacy and Safety of the Oncolytic Herpes Simplex Virus rRp450 Alone and Combined With Cyclophosphamide

Mark A. Currier, Rebecca A. Gillespie, Nancy Sawtell et al. · Molecular Therapy · 2008 · 68 citations · Full text

Medicine, Oncology, Pharmacology +17

The non-nucleoside antiviral, BAY 38-4766, protects against cytomegalovirus (CMV) disease and mortality in immunocompromised guinea pigs

Mark R. Schleiss, David I. Bernstein, Michael A. McVoy et al. · Antiviral Research · 2004 · 34 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +11

Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine

Mark R. Schleiss, Greg Stroup, Kelly Pogorzelski et al. · Vaccine · 2006 · 33 citations

Veterinary Medicine, Immunology, Infectious Diseases +16